CollPlant Biotechnologies Ltd (NAS:CLGN)
$ 6.17 -0.02 (-0.32%) Market Cap: 70.67 Mil Enterprise Value: 47.16 Mil PE Ratio: 0 PB Ratio: 2.49 GF Score: 46/100

Collplant Biotechnologies Ltd at MicroCap Rodeo: Fall Harvest Best Ideas Conference (Virtual) Transcript

Oct 05, 2021 / 12:30PM GMT
Release Date Price: $16
Operator

Good day, ladies and gentlemen, and welcome to MicroCap Rodeo's Fall Harvest Best Ideas Conference. The first presenting company is CollPlant. (Operator Instructions)

I'd now like to turn the floor over to today's host, Yehiel Tal, CEO of CollPlant. Sir, the floor is yours.

Yehiel Tal
CollPlant Biotechnologies Ltd. - CEO

Thank you and good morning. Imagine a future where there will be an unlimited supply of spare parts for the human body, including life-saving organs such as heart, kidney, lungs, and liver or tissues of all kinds like cornea, skin, heart valves, tendons, cartilage, et cetera, that drugs will be developed without the need for animal testing, and that medical treatment will be tailored to the individual characteristics of each patient.

Well, CollPlant is a regenerative and aesthetic medicine company, and we are developing innovative technologies for products for tissue regeneration and organ manufacturing. Our products are based on our technology to mass produce type 1 recombinant human collagen in genetically engineered

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot